JoAnne Flynn
Prof JoAnne Flynn has a Bachelor of Science in Biochemistry, from the University of California at Davis and a PhD from University of California at Berkeley in Microbiology and Immunology. Dr. Flynn’s first post-doc was with Dr. Magdalene So at the Scripps Clinic Research Institute and then a Howard Hughes Research Associate with Dr. Barry Bloom at Albert Einstein College of Medicine where she began her studies in tuberculosis. Dr. Flynn joined the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine in 1994 and in 2019 was awarded the title of Distinguished Professor. Dr. Flynn directs a NIH T32 Training Program and has multiple grants from NIH and the Gates Foundation. She is a current Section Editor for PLoS Pathogens and former member of the NIH NIAID Board of Scientific Counselors. She served as a Councilor for the American Association of Immunologists and as President in 2018. Dr. Flynn is a Fellow of the American Academy of Microbiologists and a Distinguished Fellow of the American Association of Immunology. She has published over 200 papers. Dr. Flynn won the University of Pittsburgh School of Medicine Distinguished Mentor Award in 2018 and Distinguished Research Award in 2019. Her research in tuberculosis is focused on immunology, host-pathogen interactions, vaccines, and drugs, and she has developed and used non-human primate models for TB research for more than 20 years. Dr. Flynn’s research uses cutting-edge tools and technologies to investigate the complexities of Mycobacterium tuberculosis infection, with a particular focus on lung and lymph node granulomas, vaccines and treatments.
Abstracts this author is presenting: